Proposition 71 is the state ballot initiative that created California’s Stem Cell Agency. This month, the Agency reached another milestone when the 71st clinical trial was initiated in the CIRM Alpha Stem Cell Clinics (ASCC) Network. The ASCC Network deploys specialized teams of doctors, nurses and laboratory technicians to conduct stem cell clinical trials at leading California Medical Centers.
These teams work with academic and industry partners to support patient-centered for over 40 distinct diseases including:
- Amyotrophic Lateral Sclerosis (ALS)
- Brain Injury & Stroke
- Cancer at Multiple Sites
- Diabetes Type 1
- Eye Disease / Blindness Heart Failure
- HIV / AIDS
- Kidney Failure
- Severe Combined Immunodeficiency (SCID)
- Sickle Cell Anemia
- Spinal Cord Injury
These clinical trials have treated over 400 patients and counting. The Alpha Stem Cell Clinics are part of CIRM’s Strategic Infrastructure. The Strategic Infrastructure program which was developed to support the growth of stem cell / regenerative medicine in California. A comprehensive update of CIRM’s Infrastructure Program was provided to our Board, the ICOC.
CIRM’s infrastructure catalyzes stem cell / regenerative medicine by providing resources to all qualified researchers and organizations requiring specialized expertise. For example, the Alpha Clinics Network is supporting clinical trials from around the world.
Many of these trials are sponsored by commercial companies that have no CIRM funding. To date, the ASCC Network has over $27 million in contracts with outside sponsors. These contracts serve to leverage CIRMs investment and provide the Network’s medical centers with a diverse portfolio of clinical trials to address patients’’ unmet medical needs.
Alpha Clinics – Key Performance Metrics
- 70+ Clinical Trials
- 400+ Patients Treated
- 40+ Disease Indications
- Over $27 million in contracts with commercial sponsors
The CIRM Alpha Stem Cell Clinics and broader Infrastructure Programs are supporting stem cell research and regenerative medicine at every level, from laboratory research to product manufacturing to delivery to patients. This infrastructure has emerged to make California the world leader in regenerative medicine. It all started because California’s residents supported a ballot measure and today we have 71 clinical trials for 71.
The Stem Cellar 
You forgot to mention Stanford
Dr ggsry steinberg has done some trials on stroke recovery
Marie frisch-koehler
Will it go on the ballot again for more funding
On Mon, Dec 17, 2018 at 10:27 AM The Stem Cellar wrote:
> Kevin McCormack posted: “Proposition 71 is the state ballot initiative > that created California’s Stem Cell Agency. This month, the Agency reached > another milestone when the 71st clinical trial was initiated in the CIRM > Alpha Stem Cell Clinics (ASCC) Network. The ASCC Network depl” >
That’s certainly a possibility. It’s not something we, as a California state agency, would do but there are other groups considering doing this for 2020